pcDNA3.1-GoldenGate-VP64 Citations (3)
Originally described in: Synergistic and tunable human gene activation by combinations of synthetic transcription factors.Perez-Pinera P, Ousterout DG, Brunger JM, Farin AM, Glass KA, Guilak F, Crawford GE, Hartemink AJ, Gersbach CA Nat Methods. 2013 Mar;10(3):239-42. doi: 10.1038/nmeth.2361. Epub 2013 Feb 3. PubMed Journal
Articles Citing pcDNA3.1-GoldenGate-VP64
Articles |
---|
Design, Assembly, and Characterization of TALE-Based Transcriptional Activators and Repressors. Thakore PI, Gersbach CA. Methods Mol Biol. 2016;1338:71-88. doi: 10.1007/978-1-4939-2932-0_7. PubMed |
Engineered TALE Repeats for Enhanced Imaging-Based Analysis of Cellular 5-Methylcytosine. Munoz-Lopez A, Jung A, Buchmuller B, Wolffgramm J, Maurer S, Witte A, Summerer D. Chembiochem. 2021 Feb 15;22(4):645-651. doi: 10.1002/cbic.202000563. Epub 2020 Nov 6. PubMed |
Optochemical Control of TET Dioxygenases Enables Kinetic Insights into the Domain-Dependent Interplay of TET1 and MBD1 while Oxidizing and Reading 5-Methylcytosine. Lin TC, Palei S, Summerer D. ACS Chem Biol. 2022 Jul 15;17(7):1844-1852. doi: 10.1021/acschembio.2c00245. Epub 2022 Jun 16. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.